Pacific Biosciences (DE:P09)

Pacific Biosciences (P09) Financial Statements


Pacific Biosciences Financial Overview

Pacific Biosciences's market cap is currently ―. The company's EPS TTM is €-1.343; its P/E ratio is -8.97; Pacific Biosciences is scheduled to report earnings on August 2, 2023, and the estimated EPS forecast is €-0.30. See an overview of income statement, balance sheet, and cash flow financials.
Mar 23Dec 22Sep 22Jun 22Mar 22
Income Statement-
Total Revenue$ 38.90M$ -68.64M$ 32.31M$ 35.47M$ 33.17M
Gross Profit$ 9.76M$ 23.33M$ 13.55M$ 16.19M$ 14.15M
EBIT$ -84.39M$ -96.30M$ -73.46M$ -67.71M$ -77.95M
EBITDA$ -84.20M$ -96.12M$ -69.15M$ -63.45M$ -73.76M
Net Income Common Stockholders$ -88.02M$ -84.38M$ -76.97M$ -71.39M$ -81.50M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 875.19M$ 772.62M$ 834.34M$ 899.15M$ 962.77M
Total Assets$ 1.90B$ 1.77B$ 1.82B$ 1.88B$ 1.94B
Total Debt$ 944.83M$ 946.64M$ 948.30M$ 950.22M$ 952.02M
Net Debt$ 69.63M$ 174.02M$ 113.96M$ 51.07M$ -10.76M
Total Liabilities$ 1.20B$ 1.77B$ 1.19B$ 1.19B$ 1.20B
Stockholders Equity$ 692.12M$ 562.90M$ 626.59M$ 681.89M$ 734.58M
Cash Flow-
Free Cash Flow$ -98.41M$ -70.25M$ -67.24M$ -64.58M$ -82.67M
Operating Cash Flow$ -94.69M$ -65.16M$ -63.05M$ -60.56M$ -79.03M
Investing Cash Flow$ -72.55M$ 85.00M$ 53.91M$ -60.28M$ 42.05M
Financing Cash Flow$ 195.99M$ 819.00K$ 3.13M$ 455.00K$ 5.21M
Currency in USD

Pacific Biosciences Earnings and Revenue History

Pacific Biosciences Debt to Assets

Pacific Biosciences Cash Flow

Pacific Biosciences Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis